✦ LIBER ✦

Rifaximin Improves Driving Simulator Performance in a Randomized Trial of Patients With Minimal Hepatic Encephalopathy

✍ Scribed by Jasmohan S. Bajaj; Douglas M. Heuman; James B. Wade; Douglas P. Gibson; Kia Saeian; Jacob A. Wegelin; Muhammad Hafeezullah; Debulon E. Bell; Richard K. Sterling; R. Todd Stravitz; Michael Fuchs; Velimir Luketic; Arun J. Sanyal

Book ID: 119761710
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 787 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2010.08.061

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rifaximin Improves Psychometric Performa

Rifaximin Improves Psychometric Performance and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy (The RIME Trial)

✍ Sidhu, Sandeep Singh; Goyal, Omesh; Mishra, Bholeshwar Prashad; Sood, Ajit; Chhi 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 255 KB

Rifaximin Improves Cognitive Functions a

Rifaximin Improves Cognitive Functions and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial (The RIME Trial)

✍ Sidhu, Sandeep; Goyal, Omesh; Mishra, Bholeshwar P.; Sood, Ajit; Chhina, Rajoo S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 111 KB

15 RIFAXIMIN TREATMENT IMPROVED QUALITY

15 RIFAXIMIN TREATMENT IMPROVED QUALITY OF LIFE IN PATIENTS WITH HEPATIC ENCEPHALOPATHY: RESULTS OF A LARGE, RANDOMIZED, PLACEBO-CONTROLLED TRIAL

✍ A. Sanyal; N. Bass; K. Mullen; F. Poordad; A. Shaw; K. Merchant; E. Bortey; W.P. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 75 KB

O169 RIFAXIMIN VERSUS LACTULOSE IN THE T

O169 RIFAXIMIN VERSUS LACTULOSE IN THE TREATMENT OF MINIMAL HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS: A PROSPECTIVE, RANDOMIZED, ACTIVE-COMPARATOR, NON-INFERIORITY TRIAL

✍ Goyal, O.; Sidhu, S.S.; Parker, R.A.; Prasad, J.; Kishore, H.; Sood, A.; Mehta, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 61 KB

207 SAFETY OF RIFAXIMIN IN PATIENTS WITH

207 SAFETY OF RIFAXIMIN IN PATIENTS WITH HEPATIC ENCEPHALOPATHY: RESULTS OF A RANDOMIZED, PHASE 3, PLACEBO-CONTROLLED CLINICAL TRIAL

✍ K. Mullen; S. Sigal; M. Sheikh; N. Bass; F. Poordad; K. Merchant; S. Huang; A. S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Randomised clinical trial: rifaximin imp

Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy – a double-blind placebo-controlled study

✍ A. Sanyal; Z. M. Younossi; N. M. Bass; K. D. Mullen; F. Poordad; R. S. Brown; R. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB